Dawnrays Pharmaceutical (Holdings) Financial Health

Short Term Liabilities: 2348's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥543.3M).

Long Term Liabilities: 2348's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥250.9M).

Debt Level: 2348 has more cash than its total debt.

Reducing Debt: 2348's debt to equity ratio has increased from 0% to 1% over the past 5 years.

Debt Coverage: 2348's debt is well covered by operating cash flow (2096.3%).

Interest Coverage: 2348 earns more interest than it pays, so coverage of interest payments is not a concern.

• Healthy companies in the Pharmaceuticals & Biotech industry.